SYNAPTISE SPÓŁKA AKCYJNA
UL. MARSZ. JÓZEFA PIŁSUDSKIEGO 74 / 320, 50-020 WROCŁAW
TAX ID8961530298
Rate company:
SYNAPTISE SPÓŁKA AKCYJNA
TAX ID8961530298
KRS0000521840
Share capital666,800.00 zł
address
UL. MARSZ. JÓZEFA PIŁSUDSKIEGO 74 / 320, 50-020 WROCŁAW
Website
www.synaptise.comCategories
Main category
Is this your company?Update company information to get new customers, get notified of new reviews, and more!
Register Data
NIP
8961530298 
REGON
021861088
KRS
0000521840
Legal form
joint stock company
Register Address
UL. MARSZ. JÓZEFA PIŁSUDSKIEGO 74 / 320, 50-020 WROCŁAW
Date of registration in KRS
2014-09-11
Date of commencement of economic activity
2014-09-11
Act signature
WR.VI NS-REJ.KRS/17353/23/626
Website
WWW.SYNAPTISE.COM
Pkd codes
72.11.Z - Research and experimental development on biotechnology
26.11.Z - Manufacture of electronic components
26.51.Z - Manufacture of instruments and appliances for measuring, testing and navigation
26.70.Z - Manufacture of optical instruments and photographic equipment
70.10.Z - Activities of head office and holding companies, excluding financial holding companies
71.20.B - Other technical testing and analysis
74.10.Z - Specialised design activities
Payer VAT status
Unregirestered
Financial data
Net sales [PLN]
Gross profit / loss [PLN]
Automatically generated based on financial statements from KRS Registry
| 2018 | 2019 | 2020 | ||
|---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Assets  | 2 | 1,5 | 1 | -33,9 |
Gross profit (loss) | -0,2 | -0,3 | -0,3 | -10,6 |
EBITDA | 0,2 | 0,2 | 0,2 | -16,8 |
Net profit (loss) | -0,2 | -0,3 | -0,3 | -10,6 |
Cash | 0 | 0 | 0 | -95,2 |
Liabilities and provisions for liabilities | 0,8 | 0,6 | 0,5 | -29,6 |
Net income from sale | 0 | 0,1 | 0 | -45,2 |
Short time liabilities | 0,4 | 0,1 | 0,1 | 27,8 |
Working assets | 0,2 | 0,3 | 0,2 | -16,1 |
Equity capital | 1,2 | 0,9 | 0,6 | -37,1 |
Operating profit (EBIT) | -0,2 | -0,3 | -0,3 | -10,5 |
Depreciation | 0,5 | 0,5 | 0,5 | -0,1 |
% | % | % | p.p. | |
Profitability of capital | -20,8 | -33,5 | -58,8 | -25,3 |
Equity capital to total assets | 58 | 58 | 55,2 | -2,8 |
Gross profit margin | -708,9 | -330,2 | -666,3 | -336,1 |
EBITDA Margin | 730,4 | 209,4 | 318,1 | 108,7 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 4044 | 252 | 587 | 335 |
Financial statements
01-01-2020 - 31-12-2020
Annual financial report
Download xml01-01-2020 - 31-12-2020
Annual financial report
Download doc01-01-2020 - 31-12-2020
Activity report
Download xml01-01-2020 - 31-12-2020
Auditor's opinion / report on the audit of the annual financial statements
Download pdf01-01-2020 - 31-12-2020
Resolution or decision approving the annual financial statements
Download pdf01-01-2020 - 31-12-2020
Resolution or decision approving the annual financial statements
Download doc01-01-2020 - 31-12-2020
Resolution or decision approving the annual financial statements
Download doc01-01-2020 - 31-12-2020
Resolution on profit distribution or loss coverage
Download pdfShow more (5)
uses security reCAPTCHA
Opinions
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane
0/ 5.0
How do you rate this company?
Your opinion matters to us.
Companies registered in the same sector
INVIGEN SPÓŁKA AKCYJNA
WARSZAWA
Bioenola sp. z o.o. w likwidacji
Olsztyn
KATARZYNA PAWEŁCZYK SCINT
Wrocław
Sandra Cytacka
WARZYMICE